São Paulo, June 10, 2026, 15:05 (BRT)
- Ambev’s NYSE ADR traded near $3.12, barely moving after a volatile two-day stretch. In Brazil, ABEV3 hovered close to R$16.20.
- The near-term focus moves off last month’s earnings rally and onto Ambev’s interest-on-capital payout schedule and the next earnings test.
Ambev S.A. ADRs were steady on Wednesday, changing hands near $3.12. The stock climbed 1.63% on Tuesday after falling 1.60% on Monday. The earnings catalyst has faded, so traders are weighing if Ambev’s run in May can keep going with the help of dividends, margins, and what’s coming in the next quarter.
Ambev’s ABEV3 shares traded around R$16.19 in São Paulo, moving between R$16.13 and R$16.27 on the session. The Ibovespa index was off roughly 0.6% during the day. Ambev didn’t look like a breakout, instead trading like a name settling down after a fast move.
Ambev hasn’t offered any new catalyst since yesterday. The company’s most recent SEC filing on May 29 was a registration form for 2026, with details on things like corporate profile, ABEV3’s B3 listing, auditor, and investor-relations contact. No fresh operating update there.
The payout calendar is back in focus. Ambev said its board cleared a July 6 payment for the second part of 2025 interest on capital (IOC) at a gross R$0.0755 per share, or R$0.0642 net after tax. IOC, used in Brazil, works as an income payment to investors, with taxes taken out before the money is paid.
The company signed off on a 2026 IOC payout at R$0.0449 gross a share, or R$0.0370 net after normal tax. B3 shareholders need to be on the books as of June 22, and NYSE ADR holders by June 24. Shares and ADRs start trading ex-IOC on June 23, so anyone buying on or after that date won’t qualify for the distribution.
U.S. investors watch the details here because ABEV trades as an ADR, meaning it’s a U.S. certificate tied to shares listed overseas. On Citi’s depositary-receipt page, Ambev’s NYSE ADR is shown at a 1:1 ratio with the ordinary Brazilian share, so the American ticker represents one ordinary share.
Ambev’s payout is drawing notice after its first-quarter numbers showed the stock’s cash flow and margins again. CEO Carlos Lisboa said the quarter offered “a solid start to 2026,” with higher beer volumes, double-digit normalized EBITDA gain and better margins. Normalized EBITDA here is what Ambev uses for earnings before interest, taxes, depreciation and amortization, with extra adjustments for what it calls items outside normal ops.
Results showed more strength than the headline suggested. Organic net revenue climbed 8.1%. Normalized EBITDA was up 10.1%. Margin on normalized EBITDA hit 33.6%, which is 60 basis points higher than before. Operating cash flow jumped 162.5% to R$3.16 billion, helped by the increase in EBITDA and improved working capital.
Ambev shares stayed quiet today as investors looked past the top-line growth. Consolidated organic volume ticked up just 0.1% in the first quarter. Most of the revenue increase was from higher net revenue per hectoliter, up 8.0%. Brazil Beer volume rose 1.2%. Volumes fell in Latin America South, Canada, and Brazil non-alcoholic drinks.
That’s why traders are more cautious after May’s big move. The ADR shot up 16.21% on May 5 when first-quarter numbers came out, hit a 52-week high at $3.45, but has since slid back to trade near $3.12. Still, that keeps it up from the 52-week low at $2.10, though the quick lift for the rerating looks done.
Costs and currency could hit margins before the next earnings. Ambev said first-quarter cash COGS per hectoliter rose 8.5%, mostly on FX and commodity moves. Guidance for Brazil Beer cash COGS/hl stays at a 4.5% to 7.5% rise for the year. Ambev also booked R$537.6 million in losses on derivatives, in part from hedging carry costs on FX and commodity exposure.
Next up for Ambev are a few near-term markers. The ex-IOC date lands June 23, with the 2025 IOC tranche payment due July 6. The next earnings release is set for July 30. That update will show if Ambev’s Q1 margin gains and cash generation stuck once the payout story slipped out of focus.